Bill Type
Congress Name
Long Title
AN ACT REGULATING THE PRICES OF DRUGS AND OTHER PHARMACEUTICAL PRODUCTS CREATING THE DRUG PRICES REGULATION BOARD AND FOR OTHER PURPOSES
Date filed
July 3, 2007
Scope
Legislative History
| House Bill/Resolution NO. HB00717 | |
| FULL TITLE : AN ACT REGULATING THE PRICES OF DRUGS AND OTHER PHARMACEUTICAL PRODUCTS CREATING THE DRUG PRICES REGULATION BOARD AND FOR OTHER PURPOSES | |
| SHORT TITLE : "Drug Prices Regulation Act" | |
| ABSTRACT : "Drug Prices Regulation Act". The bill calls for the creation of a Drug Prices Regulation Board that shall primarily function as a regulatory body to control and regulate the prices of drugs and pharmaceutical products. | |
| PRINCIPAL AUTHOR/S : PINGOY, ARTHUR "DODO" JR. Y. M.D. | |
| DATE FILED : 2007-07-03 | |
| SIGNIFICANCE: NATIONAL | |
| CO-AUTHORS (Journal Entries) : | |
| 1. Almario (017 ) | 2. Gunigundo (021 ) |
| 3. Ramiro (028 ) | 4. Lazatin (030 ) |
| 5. Soon-Ruiz (068 ) | |
| ACTIONS TAKEN BY THE COMMITTEE | |
| COMMITEE HEARINGS/ACTIONS: | |
| 1. Scheduled for first meeting/hearing on 2007-09-11 | |
| 2. Under deliberation by the Mother Committee on 2007-09-19 | |
| 3. Under deliberation by the Mother Committee on 2007-09-20 | |
| 4. Under deliberation by the Mother Committee on 2007-09-24 | |
| 5. Under deliberation by the Mother Committee on 2007-09-25 | |
| 6. Under study by the Technical Working Group(TWG) on 2007-09-26 | |
| 7. Under study by the Technical Working Group(TWG) on 2007-09-27 | |
| 8. Under study by the Technical Working Group(TWG) on 2007-09-28 | |
| 9. Under deliberation by the Mother Committee on 2007-10-01 | |
| 10. Under deliberation by the Mother Committee on 2007-10-02 | |
| 11. Under deliberation by the Mother Committee on 2007-10-03 | |
| 12. Under deliberation by the Mother Committee on 2007-10-05 | |
| MOTHER BILL: HB02844 | |
| ACTIONS TAKEN BY THE COMMITTEE ON RULES | |
| REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2007-07-31 |
Abstract
"Drug Prices Regulation Act". The bill calls for the creation of a Drug Prices Regulation Board that shall primarily function as a regulatory body to control and regulate the prices of drugs and pharmaceutical products.
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.